Growls , just to provide some comparative weighted measurement relevance for consistency , I honestly believe that every company listed on the ASX , all 2296 of them , unfortunately generously over reward their management via remuneration and bonuses . In other words , in my opinion every ASX listed company management have their snouts in the trough . Never once have I thought any different and never once has a remuneration and bonus package given me reason to think otherwise .
All in my honest opinion ......
- Forums
- ASX - By Stock
- NOR
- Ann: Appendix 3Y - Change of Director's Interest Notice
Ann: Appendix 3Y - Change of Director's Interest Notice, page-5
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.09M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 1440 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.032 |
2 | 127000 | 0.031 |
3 | 86234 | 0.030 |
1 | 150000 | 0.027 |
5 | 550000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 1440 | 1 |
0.040 | 200000 | 1 |
0.045 | 1534501 | 2 |
0.059 | 4632 | 1 |
0.069 | 50000 | 1 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NOR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online